Gender inequalities in the treatment of osteoporosis

Maturitas

Volumn 80, Issue 2, 2015, Pages 162-169

  Bor, Andrea ^a   Matuz, Mária ^a   Gyimesi, Nóra ^a   Biczók, Zsuzsanna ^a   Soós, Gyöngyvér ^a   Doró, Péter ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Bisphosphonates; Drug utilization; Hip fracture; Osteoporosis; Sex specific differences

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM DERIVATIVE; DENOSUMAB; IBANDRONIC ACID; RISEDRONIC ACID; STRONTIUM RANELATE; VITAMIN D; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT; CALCIUM INTAKE; THIOPHENE DERIVATIVE;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG USE; DRUG UTILIZATION; FEMALE; FINLAND; FRAGILITY FRACTURE; GROUPS BY AGE; HIP FRACTURE; HUMAN; HUNGARY; MALE; MONOTHERAPY; NORWAY; OSTEOPOROSIS; SCREENING; SEX DIFFERENCE; AGE; AGED; CALCIUM INTAKE; EUROPE; FACTUAL DATABASE; HEALTH CARE DISPARITY; MIDDLE AGED; SOCIOECONOMICS; THERAPEUTIC USE; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; DATABASES, FACTUAL; DENOSUMAB; DIPHOSPHONATES; DRUG UTILIZATION; EUROPE; FEMALE; FINLAND; HEALTHCARE DISPARITIES; HUMANS; HUNGARY; MALE; MIDDLE AGED; NORWAY; OSTEOPOROSIS; SEX FACTORS; SOCIOECONOMIC FACTORS; THIOPHENES; VITAMIN D;

EID: 84922570463     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.11.001     Document Type: Article

References (30)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagno-sis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA2001;6: 785-95.
2. Hernlund E, Svedbom A, Ivergard M, et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report preparedin collaboration with the International Osteoporosis Foundation (IOF) and theEuropean Federation of Pharmaceutical Industry Associations (EFPIA). ArchOsteoporos 2013;1-2: 136.
3. Cawthon PM. Gender differences in osteoporosis and fractures. Clin OrthopRelat Res 2011;7: 1900-5.
4. Hungarian Society of Osteoporosis and Osteoarthrology. Recognition, pre-vention and treatment of osteoporosis (Article in Hungarian). Ca & Bone2008;11: 4-56.
5. Wilk R, Skrzypek M, Kowalska M, et al. Standardized incidence and trend ofosteoporotic hip fracture in Polish women and men: A nine year observation.Maturitas 2014;1: 59-63.
6. Willems JM, de Craen AJ, Nelissen RG, van Luijt PA, Westendorp RG, Blauw GJ.Haemoglobin predicts length of hospital stay after hip fracture surgery in olderpatients. Maturitas 2012;3: 225-8.
7. Forsen L, Sogaard AJ, Meyer HE, Edna T, Kopjar B. Survival after hip fracture: Short- and long-term excess mortality according to age and gender. OsteoporosInt 1999;1: 73-8.
8. Horváth C (Article in Hungarian) Osteoporosis - not only disease, but invest-ment?; 2008. http://hetivalasz.hu/pr/a-csontritkulas-nemcsak-betegseg-hanem-befektetes-is-38258/?cikk ertekel=1& ertekeles=1 (accessed 04.0414).
9. Birkett DJ. The future of ATC/DDD and drug utilization research. WHO DrugInform 2002;16: 238-40.
10. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATCclassification and DDD assignment. Oslo: Norwegian Institute of Public Health;2013.
11. Souich P, Orme M, Erill S. The IUPHAR compendium of basic principles forpharmacological research in humans. Irvine: IUPHAR Administrative Office;2014.
12. Hungarian Central Statistical Office. Available at: Http://statinfo.ksh.hu/Statinfo/themeSelector.jsp?page= 2&szst=WNT (accessed 24.02.14).
13. Estonian drug consumption database. Available at: Http://pxweb.tai.ee/esf/pxweb2008/Database en/Medicines/Medicines/Medicines.asp (accessed14.04.14).
14. Finnish Medicines Agency Fimea and Social Insurance Institution. Finnishstatistics on medicines 2010 Helsinki: Finnish Medicines Agency; 2011.
15. Estonian State Agency of Medicines. Baltic statistics on medicines 2010-2012.Tartu: Estonian State Agency of Medicines; 2013, ISBN 978-9949-33-396-7.
16. Norwegian Prescription Database. Available at: Http://www.norpd.no/Prevalens.aspx (accessed on 20.05.14).
17. Hollingworth SA, Gunanti I, Nissen LM, Duncan EL. Secondary prevention ofosteoporosis in Australia: Analysis of government-dispensed prescription data.Drugs Aging 2010;3: 255-64.
18. Laurent M, Gielen E, Claessens F, Boonen S, Vanderschueren D. Osteoporosis inolder men: Recent advances in pathophysiology and treatment. Best Pract ResClin Endocrinol Metab 2013;4: 527-39.
19. Gielen E, Vanderschueren D, Callewaert F, Boonen S. Osteoporosis in men. BestPract Res Clin Endocrinol Metab 2011;2: 321-35.
20. Kaufman JM, Audran M, Bianchi G, et al. Efficacy and safety of strontiumranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab2013;2: 592-601.
21. Boonen S, Lorenc RS, Wenderoth D, Stoner KJ, Eusebio R, Orwoll ES. Evidencefor safety and efficacy of risedronate in men with osteoporosis over 4 yearsof treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study. Bone 2012;3: 383-8.
22. Tables of basic data on Hungarian health care. Available at: Http://tea.gyemszi.hu/(accessed 20.03.14).
23. White SC, Atchison KA, Gornbein JA, Nattiv A, Paganini-Hill A, Service SK. Riskfactors for fractures in older men and women: The Leisure World Cohort Study.Gend Med 2006;2: 110-23.
24. Lippuner K, Johansson H, Kanis JA, Rizzoli R. Remaining lifetime and abso-lute 10-year probabilities of osteoporotic fracture in Swiss men and women.Osteoporos Int 2009;7: 1131-40.
25. World Health Organisation life expectancy. Available at: Http://apps.who.int/gho/data/node.main.3?lang=en (accessed 20.03.14).
26. Johnell K, Fastbom J. Undertreatment of osteoporosis in the oldest old?A nationwide study of over 700, 000 older people. Arch Osteoporos2009;1-2: 17-23.
27. Karjalainen J [dissertation] Novel pulse-echo ultrasound methods for diagnos-tics of osteoporosis; 2011.
28. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and associationwith bone mineral density in elderly men and women: The Rotterdam Study.Bone 2004;1: 195-202.
29. FRAX test. Available at: Https://www.shef.ac.uk/FRAX/(accessed on 2404.14).
30. Compston J. Strontium ranelate lives to fight another day. Maturitas2014;2: 75-6.